Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • frozenlyse
    Senior Member
    • Sep 2008
    • 135

    unique mapping for chip-seq?

    Ok so I am re-analysing some publicly available chip-seq data (human H3K4me3 & H3K27me3) and have a few questions

    at the moment my "pipeline" is to align reads with bowtie (using --best), convert to maq format and generate .wigs & peaks with findpeaks

    Comparing to the publication, I am mapping 29M/40M reads, where they only mapped ~9M so i believe they are throwing out reads which map equally well to multiple places in the genome, whereas bowtie is reporting a random sampling of the best alignments (ala maq).

    does anyone have thoughts on which way is better to go for chip-seq peak finding?
  • Chipper
    Senior Member
    • Mar 2008
    • 323

    #2
    What setting did you use for bowtie (-n or -v) and what read lengths was it. I think default for bowti is to use up to 2 mm in the good part of reads (first 28 bases or so), -v 2 would mean up to 2 mm in the full sequence.

    Probably setting a relatively low -m, or only use reads with multiple matches if they are of high quality would be best since it may be biased to report random repeat matches otherwise. But it would be very interresting to see how it affects the k27 signal since it could be present over lare distances including repeaats.

    Comment

    • frozenlyse
      Senior Member
      • Sep 2008
      • 135

      #3
      my read lengths are 36bp, and i used the default (i think this is -n 2 but im not sure!)

      i am rerunning my analysis with -m 1 to see how that changes the analysis, ill post back with the results!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 12:17 PM
      0 responses
      14 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      37 views
      0 reactions
      Last Post SEQadmin2  
      Working...